Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Posts Tagged ‘Cincinnati’

Cincinnati Bell Partners With Oregon District on Smart City Solution

Posted by fidest press agency su lunedì, 2 settembre 2019

Cincinnati Bell is partnering with the Oregon District Business Association to implement a Smart City solution in the Oregon District. Cincinnati Bell is donating the upfront charges to deploy the Smart City solution over the next 2-3 months.The Smart City solution includes the following: Installing fiber to provide free public Wi-Fi in the Oregon District, as well as analytics and engagement software to support local businesses and drive economic development. Public Wi-Fi will extend on 5th Street from Wayne Avenue to Patterson Boulevard. Cameras that will be located throughout the business district, alleyways, and various parking lots to support law enforcement safety initiatives.
Links from the Wi-Fi portal that will facilitate donations to The Dayton Foundation, and the ability for users to easily contact legislators.
“Cincinnati Bell is committed to supporting the City of Dayton and Oregon District Business Association,” said Jason Praeter, President and General Manager of Cincinnati Bell’s Entertainment and Communications business. “As a lifelong Dayton resident currently residing in Bellbrook, I am especially proud that Cincinnati Bell is a part of this important project.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Chemed To Report Fourth-Quarter 2017

Posted by fidest press agency su domenica, 14 gennaio 2018

chemed-blurCINCINNATI. Chemed Corporation (NYSE:CHE) announced that it will release financial results for the fourth quarter ended December 31, 2017, on Wednesday, February 14, 2018, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 15, 2018, to discuss the company’s quarterly results and to provide an update on its business.The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants. The participant Conference ID is 3768588. A live webcast of the call can be accessed on Chemed’s website at http://www.chemed.com by clicking on Investor Relations Home.A taped replay of the conference call will be available beginning approximately two hours after the call’s conclusion. It can be accessed by dialing toll-free 855-859-2056 for U.S. and Canadian callers and +1 404-537-3406 for international callers and will be available for one week following the live call. The replay Conference ID is 3768588. An archived webcast will also be available at http://www.chemed.com.Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.Statements in this press release or in other Chemed communications may relate to future events or Chemed’s future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations. (photo: chemed-blur)

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Kao si accinge ad acquisire Oribe Hair Care di Luxury Brand Partners

Posted by fidest press agency su venerdì, 22 dicembre 2017

kaoCINCINNATI/PRNewswire/Kao USA Inc., una filiale interamente di proprietà di Kao Corporation, produttore e distributore leader dei migliori marchi di prodotti di bellezza riconosciuti in tutto il mondo per le loro caratteristiche innovative e la loro qualità, ha annunciato oggi di aver firmato un accordo per l’acquisizione di Oribe Hair Care, LLC dai suoi proprietari, inclusa Luxury Brand Partners, LLC, una società innovatrice nel settore cosmetico nota per i suoi marchi ispirati agli artisti e la sua cultura imprenditoriale. Daniel Kaner, co-fondatore e attualmente co-presidente di Oribe Hair Care, sarà nominato presidente della nuova entità acquisita. I termini dell’accordo non sono stati resi noti.Oribe entrerà a far parte del portafoglio di marchi professionali di Kao Salon Division, tra cui Goldwell, una linea completa di prodotti per capelli di alta qualità creati in esclusiva per gli stilisti e destinati a soddisfare le esigenze professionali, e la linea KMS di prodotti per la cura e l’acconciatura dei capelli di ispirazione globale per gli stilisti creativi e i loro clienti.
Oribe è cresciuta da un prestigioso marchio per la cura dei capelli a un’autorità globale nel campo dei prodotti di bellezza che offre trattamenti per la cura dei capelli, della pelle e del corpo, trucchi, strumenti e accessori. Il marchio vanta una forte presenza nel segmento dei saloni professionali di alto livello e tra i principali rivenditori specializzati in tutto il mondo.
“Oribe è un marchio stellare e un’aggiunta perfetta al portafoglio di Kao Salon Division”, ha dichiarato Cory Couts, Presidente globale, Kao Salon Division. “Daniel costituirà un’aggiunta entusiasmante e stimolante al nostro team dirigenziale. La nomina di Daniel, oltre a garantire la continuità di tutte le straordinarie caratteristiche di Oribe, rientra anche nell’ottica di avanzamento della missione della nostra azienda di attrarre i professionisti dei saloni di bellezza più artistici e di successo del mondo”.”Kao è il luogo ideale in cui Oribe Hair Care potrà compiere il passo successivo nel suo viaggio trasformativo”, ha dichiarato Kaner. “Nutro un profondo rispetto per la loro organizzazione e il loro team dirigenziale di talento. La nostra amicizia e il nostro rapporto d’affari risalgono a parecchi anni fa; la partnership strategica negli Stati Uniti tra Oribe e Goldwell Color ha dato i maggiori frutti. Abbiamo sempre creduto che la cura dei capelli dovrebbe essere un’esperienza immersiva e di lusso, e Kao supporta pienamente lo standard elevato che ci siamo prefissati”.”Con il suo focus sui prodotti di lusso, Oribe soddisferà l’esigenza di una linea di prestigio nel mix di prodotti Kao Salon”, ha aggiunto Couts. “L’ampia rete di distribuzione globale di Kao Salon Division, inoltre, consentirà a Oribe di espandersi a livello internazionale”.
“Dire addio a un marchio che Oribe Canales, Daniel Kaner e io abbiamo fondato e creato quasi dieci anni fa è una sensazione dolce-amara”, ha dichiarato Tevya Finger, CEO di Luxury Brand Partners. “Sono estremamente orgoglioso di ciò che Oribe Hair Care è stata in grado di realizzare sin dalla sua concezione, e attendo con ansia di osservare lo sviluppo del marchio su scala globale da parte di Kao Corporation”.La sede aziendale di Oribe rimarrà a New York City con la gestione corrente, subordinata a Kao Salon Division.L’acquisizione è soggetta alle revisioni e approvazioni normative standard. (foto: oribe)

Posted in Economia/Economy/finance/business/technology | Contrassegnato da tag: , , , | Leave a Comment »

Devicor Launches New Tetherless Vacuum-Assisted Biopsy System

Posted by fidest press agency su venerdì, 20 aprile 2012

Breast biopsy

Breast biopsy (Photo credit: Wikipedia)

Cincinnati, (PRNewswire) Devicor® Medical Products, Inc. (Devicor), announced the commercial launch, on 1st May 2012, of the Mammotome® elite Biopsy System, the only tetherless single insertion, multiple sample, vacuum-assisted biopsy (VAB) device featuring proprietary TruVac™ vacuum technology. Unlike competing devices that rely on automated syringes, elite provides a vacuum that achieves nearly the same suction power of the traditional Mammotome® VAB system, enabling the device to capture large, high quality tissue samples.
The Mammotome® elite Biopsy System will be used to aid in the detection and treatment of breast cancer in ultrasound-guided breast and axillary lymph node biopsies. In March, Devicor received 510(k) clearance from the U.S. Food and Drug Administration for use on patients. The product has also received European CE marking.
The Mammotome® elite system includes a reusable holster, a charging base and a single-patient-use disposable 13-gauge probe with a bladed insertion tip. This tip is designed to move easily through tissue while allowing physicians to maintain control of the needle even in problematic dense breast tissue. The new lightweight ergonomic design of elite provides superior control for precise needle placement and easy insertion.
Says William R. Poller, M.D., FACR, Director of Breast Imaging at West Penn Allegheny Health System in Pittsburgh, PA, “What makes the Mammotome® elite device unique is its ability to provide the tissue quality of a full VAB device, with the convenience of a disposable core needle. The simplicity of elite’s design allows me to maintain my focus on the biopsy site and the single insertion device reduces procedure time, easing patient anxiety. This is a game-changing diagnostic tool.”
Tom Daulton, CEO of Devicor, says, “In the last several years, Devicor has invested heavily in developing innovative new tools that help doctors more effectively diagnose and treat breast cancer. Mammotome® elite is the first of many exciting product innovations including markers, next generation VAB and other breast biopsy products we will be bringing to patients and clinicians around the world.”
In 2011, more than 1.4 million women in the United States alone underwent a biopsy procedure with approximately 40% of those undergoing vacuum-assisted breast biopsies. VAB procedures are growing in popularity with clinicians and patients because they provide a more accurate diagnosis than traditional core needle biopsies and are less invasive than surgery.
About Devicor® Medical Products, Inc. Devicor Medical Products, headquartered in Cincinnati, Ohio, has more than 400 employees around the globe. The company is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. Devicor’s product portfolio includes the world-renowned Mammotome® Breast Biopsy System, neo2000® Gamma Detection System (GDS) and tissue markers (MammoMARK™, MicroMARK®II, and CorMARK™) used in breast disease diagnostic sampling and management. These products are sold in more than 50 countries around the world. Since its introduction in 1995, more than 4 million women have had a minimally invasive breast biopsy in stereotactic, ultrasound or MRI-guidance imaging using the Mammotome® Breast Biopsy System. For more information, please visit http://www.devicormedical.com or http://www.mammotome.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | 1 Comment »